Growth Factor Measurement and Histological Analysis in Platelet Rich Fibrin: A Pilot Study

Overview

Journal J Maxillofac Oral Surg

Date 2015 Nov 26

PMID 26604462

Citations 17

Authors

Soh Nishimoto

Kazutoshi Fujita

Yohei Sotsuka

Masato Kinoshita

Toshihiro Fujiwara

Kenichiro Kawai

Masao Kakibuchi

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to compare growth factor amount contained in platelet rich fibrin (PRF) and compare with that in platelet rich plasma (PRP), and in whole blood. And also to investigate distribution of growth factors and cellular components in PRF.

Materials And Methods: PRF and PRP were obtained from the same sample of peripheral blood. Extraction of proteins were done with lysis buffer, accompanied by freeze and thaw procedures. Concentration of two representative growth factors in platelets: platelet derived growth factor (PDGF) and transforming growth factor beta (TGF-β), were measured with enzyme-linked immunosorbent assay (ELISA). PRF was cut into three parts: (top, middle and bottom), and growth factor concentration was measured respectively. Paraffin embedded section of PRF was observed with Giemsa stain. Immuno-histochemical analysis with anti-PDGF and anti-TGF-β antibodies was also conducted.

Results: The growth factor levels in PRF was higher than in peripheral blood and comparable to those in PRP. Growth factor levels in bottom part of PRF was much higher than in top and middle part. Microscopically, platelets and mono-nucleated cells were concentrated just above the yellow-red interface. Poly-nucleated cells were concentrated below the interface.

Conclusion: The growth factors were surely concentrated in PRF. This result can support basis of good clinical outcomes. For effective application of PRF, the knowledge that growth factors and cells are not equally distributed in PRF should be utilized.

Citing Articles

Antibiotic-Loaded Platelet-Rich Fibrin (AL-PRF) as a New Carrier for Antimicrobials: A Systematic Review of In Vitro Studies.

Niemczyk W, Zurek J, Niemczyk S, Kepa M, Zieba N, Misiolek M Int J Mol Sci. 2025; 26(5).

PMID: 40076763 PMC: 11899807. DOI: 10.3390/ijms26052140.

Navigating the combinations of platelet-rich fibrin with biomaterials used in maxillofacial surgery.

Ievina L, Dubnika A Front Bioeng Biotechnol. 2024; 12:1465019.

PMID: 39434715 PMC: 11491360. DOI: 10.3389/fbioe.2024.1465019.

Plasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma.

El-Derby A, Khedr M, Ghoneim N, Gabr M, Khater S, El-Badri N J Transl Med. 2024; 22(1):487.

PMID: 38773585 PMC: 11110239. DOI: 10.1186/s12967-024-05230-7.

Evaluation optimum ratio of synthetic bone graft material and platelet rich fibrin mixture in a metal 3D printed implant to enhance bone regeneration.

Wong K, Chen Y, Lin C J Orthop Surg Res. 2024; 19(1):299.

PMID: 38755635 PMC: 11097440. DOI: 10.1186/s13018-024-04784-y.

Usefulness of platelet-rich fibrin as a scaffold for meniscal repair: A non-randomized controlled cohort/follow-up study.

Kemmochi M J Orthop. 2024; 52:94-101.

PMID: 38435313 PMC: 10904893. DOI: 10.1016/j.jor.2024.02.009.

References

Ratnoff O, Rosenblum J . Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition. Am J Med. 1958; 25(2):160-8. DOI: 10.1016/0002-9343(58)90023-8. View

Singh A, Kohli M, Gupta N . Platelet rich fibrin: a novel approach for osseous regeneration. J Maxillofac Oral Surg. 2013; 11(4):430-4. PMC: 3485469. DOI: 10.1007/s12663-012-0351-0. View

Marx R, Carlson E, Eichstaedt R, Schimmele S, Strauss J, Georgeff K . Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 85(6):638-46. DOI: 10.1016/s1079-2104(98)90029-4. View

Ruga E, Gallesio C, Boffano P . Platelet-rich fibrin and piezoelectric surgery: a safe technique for the prevention of periodontal complications in third molar surgery. J Craniofac Surg. 2011; 22(5):1951-5. DOI: 10.1097/SCS.0b013e31822ea76b. View

Oyama T, Nishimoto S, Tsugawa T, Shimizu F . Efficacy of platelet-rich plasma in alveolar bone grafting. J Oral Maxillofac Surg. 2004; 62(5):555-8. DOI: 10.1016/j.joms.2003.08.023. View

Sharma A, Pradeep A . Treatment of 3-wall intrabony defects in patients with chronic periodontitis with autologous platelet-rich fibrin: a randomized controlled clinical trial. J Periodontol. 2011; 82(12):1705-12. DOI: 10.1902/jop.2011.110075. View

Ross R . Platelets: cell proliferation and atherosclerosis. Metabolism. 1979; 28(4 Suppl 1):410-4. DOI: 10.1016/0026-0495(79)90047-7. View

Assoian R, Komoriya A, Meyers C, Miller D, Sporn M . Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983; 258(11):7155-60. View

Chignon-Sicard B, Georgiou C, Fontas E, David S, Dumas P, Ihrai T . Efficacy of leukocyte- and platelet-rich fibrin in wound healing: a randomized controlled clinical trial. Plast Reconstr Surg. 2012; 130(6):819e-829e. DOI: 10.1097/PRS.0b013e31826d1711. View

10.

Nishimoto S, Oyama T, Matsuda K . Simultaneous concentration of platelets and marrow cells: a simple and useful technique to obtain source cells and growth factors for regenerative medicine. Wound Repair Regen. 2007; 15(1):156-62. DOI: 10.1111/j.1524-475X.2006.00196.x. View

11.

Wilner G, Nossel H, LeRoy E . Activation of Hageman factor by collagen. J Clin Invest. 1968; 47(12):2608-15. PMC: 297431. DOI: 10.1172/JCI105943. View

12.

Eppley B, Woodell J, Higgins J . Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004; 114(6):1502-8. DOI: 10.1097/01.prs.0000138251.07040.51. View

13.

Dohan D, Choukroun J, Diss A, Dohan S, Dohan A, Mouhyi J . Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101(3):e45-50. DOI: 10.1016/j.tripleo.2005.07.009. View

14.

Dohan D, Choukroun J, Diss A, Dohan S, Dohan A, Mouhyi J . Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101(3):e37-44. DOI: 10.1016/j.tripleo.2005.07.008. View

15.

Saluja H, Dehane V, Mahindra U . Platelet-Rich fibrin: A second generation platelet concentrate and a new friend of oral and maxillofacial surgeons. Ann Maxillofac Surg. 2013; 1(1):53-7. PMC: 3591032. DOI: 10.4103/2231-0746.83158. View

16.

Margolis J . Initiation of blood coagulation by glass and related surfaces. J Physiol. 1957; 137(1):95-109. PMC: 1363001. DOI: 10.1113/jphysiol.1957.sp005799. View

17.

Rao S, Bhat P, Nagesh K, Rao G, Mirle B, Kharbhari L . Bone regeneration in extraction sockets with autologous platelet rich fibrin gel. J Maxillofac Oral Surg. 2014; 12(1):11-6. PMC: 3589514. DOI: 10.1007/s12663-012-0370-x. View

18.

Wiltfang J, Kloss F, Kessler P, Nkenke E, Schultze-Mosgau S, Zimmermann R . Effects of platelet-rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical-size defects. An animal experiment. Clin Oral Implants Res. 2004; 15(2):187-93. DOI: 10.1111/j.1600-0501.2004.00980.x. View

19.

Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B . Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004; 30(2):145-51. DOI: 10.1016/j.transci.2004.01.004. View